Analytic Investors’s Genpact G Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
$19.2M Buy
800,291
+588,476
+278% +$14.6M 0.21% 104
2016
Q2
$5.68M Buy
211,815
+100,381
+90% +$2.76M 0.07% 181
2016
Q1
$3.03M Hold
111,434
0.04% 250
2015
Q4
$2.78M Buy
111,434
+21,983
+25% +$544K 0.03% 249
2015
Q3
$2.11M Buy
89,451
+100
+0.1% +$2.25K 0.03% 283
2015
Q2
$1.91M Sell
89,351
-113
-0.1% -$2.53K 0.03% 290
2015
Q1
$2.08M Sell
89,464
-31
-0% -$668 0.03% 262
2014
Q4
$1.69M Sell
89,495
-166
-0.2% -$2.92K 0.02% 273
2014
Q3
$1.46M Hold
89,661
0.02% 305
2014
Q2
$1.57M Hold
89,661
0.03% 270
2014
Q1
$1.56M Buy
+89,661
New +$1.51M 0.02% 309
2013
Q3
Sell
-37,333
Closed -$718K 525
2013
Q2
$718K Buy
+37,333
New +$709K 0.01% 396

Other funds holding G

Analytic Investors's G Position: Q3 2016 in Review

Analytic Investors increased its Genpact (G) stake by 278% in Q3 2016, buying an estimated $14.6M and bringing the position to 800,291 shares worth $19.2M. The position accounts for 0.21% of the portfolio, ranked #104.

Analytic Investors first reported a position in G in Q2 2013 and has held it in 12 quarters since. 211 funds tracked by Wall St. Rank hold G as of Q3 2016.

  • Analytic Investors held 800,291 shares of Genpact worth $19.2M as of Q3 2016.
  • Analytic Investors bought 588,476 Genpact shares in Q3 2016, an estimated $14.6M.
  • Genpact made up 0.21% of Analytic Investors's portfolio in Q3 2016, its #104 holding.
  • Analytic Investors first reported a position in Genpact in Q2 2013 and has held it in 12 quarters since.
  • 211 funds tracked by Wall St. Rank held Genpact as of Q3 2016.

Based on Analytic Investors's 13F filing for Q3 2016, filed 14 Nov 2016.